Related references
Note: Only part of the references are listed.A Study of ΔNp63 Expression in Lung Non-Small Cell Carcinomas
Daisuke Nonaka
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
DNA damage down-regulates ΔNp63α and induces apoptosis independent of wild type p53
Xiaorong Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Expression and Regulation of the ΔN and TAp63 Isoforms in Salivary Gland Tumorigenesis Clinical and Experimental Findings
Yoshitsugu Mitani et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The p73 Tumor Suppressor Is Targeted by Pirh2 RING Finger E3 Ubiquitin Ligase for the Proteasome-dependent Degradation
Yong-Sam Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mutant p53 Protein Is Targeted by Arsenic for Degradation and Plays a Role in Arsenic-mediated Growth Suppression
Wensheng Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
p63, a Story of Mice and Men
Hans Vanbokhoven et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Role of Pirh2 in Mediating the Regulation of p53 and c-Myc
Anne Hakem et al.
PLOS GENETICS (2011)
Dominant negative (ΔN) p63α induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways
Heiko M. Mundt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Arsenic trioxide - An old drug rediscovered
Ashkan Emadi et al.
BLOOD REVIEWS (2010)
PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
Marion Jeanne et al.
CANCER CELL (2010)
MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation
Francesco Galli et al.
JOURNAL OF CELL SCIENCE (2010)
Pirh2 E3 Ubiquitin Ligase Targets DNA Polymerase Eta for 20S Proteasomal Degradation
Yong-Sam Jung et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
Xiaohua Su et al.
NATURE (2010)
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
Jynho Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability
Jin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Xiao-Wei Zhang et al.
SCIENCE (2010)
p53-Induced Ring-H2 Protein, a Novel Marker for Poor Survival in Hepatocellular Carcinoma After Hepatic Resection
Xiao-Min Wang et al.
CANCER (2009)
TAp63 induces senescence and suppresses tumorigenesis in vivo
Xuecui Guo et al.
NATURE CELL BIOLOGY (2009)
A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia
Qun-Ye Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis
Y. Li et al.
CELL DEATH AND DIFFERENTIATION (2008)
Arsenic trioxide decreases AKT protein in a caspase-dependent manner
Koren K. Mann et al.
MOLECULAR CANCER THERAPEUTICS (2008)
p63 - Key molecule in the early phase of epithelial abnormality in idiopathic pulmonary fibrosis
Kengo Murata et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2007)
ΔNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck
L. Boldrup et al.
JOURNAL OF PATHOLOGY (2007)
Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1
Takayuki Hattori et al.
CANCER RESEARCH (2007)
Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells
Wensheng Yan et al.
CANCER RESEARCH (2007)
p63: Defining roles in morphogenesis, homeostasis, and neoplasia of the epidermis
Kathryn E. King et al.
MOLECULAR CARCINOGENESIS (2007)
Hypoxia/reoxygenation-induced cytotoxicity in cultured human lymphocytes
Jun Yeol Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide
David Shackelford et al.
CANCER RESEARCH (2006)
Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer
Ian R. Logan et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The E3 ubiquitin ligase Itch controls the protein stability of p63
Mario Rossi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Itch/AIP4 associates with and promotes p63 protein degradation
Mariangela Rossi et al.
CELL CYCLE (2006)
p63 regulates an adhesion programme and cell survival in epithelial cells
Danielle K. Carroll et al.
NATURE CELL BIOLOGY (2006)
GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner
WS Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis
JW Rocco et al.
CANCER CELL (2006)
ΔNp63α levels correlate with clinical tumor response to cisplatin
R Zangen et al.
CELL CYCLE (2005)
Tumor predisposition in mice mutant for p63 and p73:: Evidence for broader tumor suppressor functions for the p53 family
ER Flores et al.
CANCER CELL (2005)
IGFBP-3 is a direct target of transcriptional regulation by ΔNp63α in squamous epithelium
CE Barbieri et al.
CANCER RESEARCH (2005)
The common and distinct target genes of the p53 family transcription factors
K Harms et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Inhibition of mitochondrial respiration - A novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism
H Pelicano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
J Debnath et al.
METHODS (2003)
The ΔNp63α phosphoprotein binds the p21 and 14-3-3σ promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations
MD Westfall et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation
RP Leng et al.
CELL (2003)
p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes
M Dohn et al.
ONCOGENE (2001)
Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage
Y Shen et al.
LEUKEMIA (2001)
High level expression of ΔN-p63:: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?
T Crook et al.
ONCOGENE (2000)
AIS is an oncogene amplified in squamous cell carcinoma
K Hibi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
